Kaigene Inc.
PrivateLast Round
Series A
Sep 30, 2026
Total Funding Raised
$44.5M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Kaigene Inc. operates in Healthcare & Life Sciences and is based in North Bethesda, Maryland. Its latest recorded funding round was a Corporate Funding round in July 2026.
Kaigene Inc. is a biotechnology company that develops innovative antibody therapeutics and fusion proteins to address unmet clinical needs in rare autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kaigene Inc. Comparables
Compare Kaigene Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| FcR Therapeutics | 82% | |
| Cerberus Therapeutics | 76% | |
| Curogen Technology Co., Ltd. | 75% |
For institutional investors. Book with your work email.
Kaigene Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 30, 2026 | ||||
| Corporate Funding | Jul 30, 2026 | ||||
| Pre Seed | Feb 14, 2026 | ||||
| Corporate Funding | Nov 3, 2025 | ||||
| Debt | Mar 29, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Kaigene Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DSC Investment | Pre Seed |
| Yuanta Investment | Pre Seed |
| Korea Development Bank | Pre Seed |
| Celltrion | Series A, Corporate Funding, Pre Seed |
| Sazze Partners | Pre Seed |
| Atinum Investment | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 30, 2026
$69.46M round with participation from Celltrion, Daewoong Pharmaceutical, and Hanall Biopharma.
- Jul 30, 2026
$5M raised with participation from Taisho Pharmaceutical.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- licenses_technologyOct 23, 2026
Maryland-based Kaigene, Inc. licenses a preclinical antibody targeting autoimmune conditions to Celltrion Inc. in a deal worth up to $580.5 million.
- is_developingOct 23, 2026
Kaigene, Inc. is developing multi-antibody drugs based on its proprietary PDEG(TM)(Pathogenic Antibody Degrader) platform, which degrades disease-causing autoantibodies.
For institutional investors. Book with your work email.
Kaigene Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Kaigene Inc.'s valuation, stock price, and market status.
Is Kaigene Inc. a public or private company?
Kaigene Inc. is a private company.
What is the current stock price of Kaigene Inc.?
Kaigene Inc. is a private company, so its shares have no public market price. Caplight tracks Kaigene Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Kaigene Inc. worth (valuation)?
Valuation information for Kaigene Inc. is not publicly available.
Can I buy Kaigene Inc. stock?
Kaigene Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Kaigene Inc.'s last funding round?
Kaigene Inc.'s most recent funding round was Series A on September 30, 2026.
Who are the main investors in Kaigene Inc.?
Key investors in Kaigene Inc. include DSC Investment, Yuanta Investment, Korea Development Bank, Celltrion, Sazze Partners.
Will Kaigene Inc. IPO soon?
No public IPO plans have been announced for Kaigene Inc..
How can I track Kaigene Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Kaigene Inc.'s shares on secondary markets.